SHANDONG BOAN BIOTECH.H 1 (UJ9) — Capital Reinvestment Ratio
SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Capital Reinvestment Ratio of 4.22x as of December 2025, meaning it reinvests 4% of its operating cash flow (€64.89 Million) in capital expenditures (€274.05 Million). Check SHANDONG BOAN BIOTECH.H 1 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SHANDONG BOAN BIOTECH.H 1 Capital Reinvestment Ratio (2025–2025)
This chart tracks SHANDONG BOAN BIOTECH.H 1's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see UJ9 cash flow metrics.
Annual Capital Reinvestment Ratio for SHANDONG BOAN BIOTECH.H 1 (2025–2025)
Year-by-year Capital Reinvestment Ratio for SHANDONG BOAN BIOTECH.H 1 from 2025 to 2025. See UJ9 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.22x | €64.89 Million | €274.05 Million | — |